Prostate Cancer Therapeutics Report: In-Depth Analysis Into the Clinical Trials, Emerging Drugs, and Treatment Outlook | Companies – Novartis, Pfizer, Innocrin, Roche, Advantagene, Janssen, and Others

Delveinsight Business Research LLP
“Prostate Cancer Pipeline Insight, 2022″ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Prostate Cancer Market.

The Prostate Cancer Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. 

The report also covers a detailed description of the drug including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.

Prostate Cancer Pipeline Analysis

The report provides insights into: 

The report provides detailed insights about companies that are developing therapies for the treatment of Prostate Cancer with aggregate therapies developed by each company for the same.

It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Prostate Cancer Treatment.

Prostate Cancer key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

Prostate Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 

Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Prostate Cancer market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.  

Request for Sample PDF Report – @

Prostate Cancer Therapeutics Landscape

The available therapeutics treatment options in Prostate Cancer Landscape aim to provide cure to the patients suffering from this indication, however, there are several challenges that are yet to be tackled.

As per DelveInsight, the Prostate Cancer market dynamics is anticipated to change in the coming years owing to the rise in the number of companies taking interest in the development of therapies for Prostate Cancer.

Some of the Key Companies in the Prostate Cancer Market include:


Bristol-Myers Squibb


Myovant Sciences

Pharmaceuticals USA

Hoffmann-La Roche


Astellas Pharma

Innocrin Pharmaceutical

Clovis Oncology

Advantagene (Candel Therapeutics)

Merck Sharp & Dohme

And several other

Prostate Cancer Therapies covered in the report include:











And many more.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Report Introduction

2. Prostate Cancer 

3. Prostate Cancer Current Treatment Patterns

4. Prostate Cancer – DelveInsight’s Analytical Perspective

5. Therapeutic Assessment

6. Prostate Cancer Late Stage Products (Phase-III)

7. Prostate Cancer Mid Stage Products (Phase-II)

8. Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Prostate Cancer Discontinued Products

13. Prostate Cancer Product Profiles

14. Prostate Cancer Key Companies

15. Prostate Cancer Key Products

16. Dormant and Discontinued Products

17. Prostate Cancer Unmet Needs

18. Prostate Cancer Future Perspectives

19. Prostate Cancer Analyst Review  

20. Appendix

21. Report Methodology

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

Other Latest Reports By DelveInsight

Global Kinase Inhibitor in Autoimmune Diseases Market

DelveInsight’s “Global Kinase Inhibitor in Autoimmune Diseases  Market” report delivers an in-depth understanding of the Global Kinase Inhibitor in Autoimmune Diseases market size, shares, and trends analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan) as well as the emerging therapies and key companies operating in the domain.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States